Journal of International Obstetrics and Gynecology ›› 2023, Vol. 50 ›› Issue (6): 644-649.doi: 10.12280/gjfckx.20230800
• Research on Gynecological Malignancies: Review • Previous Articles Next Articles
Received:
2023-10-12
Published:
2023-12-15
Online:
2023-12-13
Contact:
LI Lei
E-mail:lileigh@163.com
CHEN Xiao-jing, LI Lei. Screening Status and Research Progress of Endometrial Cancer[J]. Journal of International Obstetrics and Gynecology, 2023, 50(6): 644-649.
Add to citation manager EndNote|Ris|BibTeX
[1] | Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. doi: 10.3322/caac.21660. |
[2] |
Clarke MA, Long BJ, Del Mar Morillo A, et al. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis[J]. JAMA Intern Med, 2018, 178(9):1210-1222. doi: 10.1001/jamainternmed.2018.2820.
pmid: 30083701 |
[3] |
Crosbie EJ, Kitson SJ, McAlpine JN, et al. Endometrial cancer[J]. Lancet, 2022, 399(10333):1412-1428. doi: 10.1016/S0140-6736(22)00323-3.
pmid: 35397864 |
[4] | ACOG Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding[J]. Obstet Gynecol, 2018, 131(5):e124-e129. doi: 10.1097/AOG.0000000000002631. |
[5] |
Ai F, Wang Y, Zhou L, et al. Clinicopathologic characteristics and risk factors for endometrial malignancy in postmenopausal women with endometrial thickening[J]. Menopause, 2022, 29(2):137-143. doi: 10.1097/GME.0000000000001903.
pmid: 35013057 |
[6] |
Du J, Li Y, Lv S, et al. Endometrial sampling devices for early diagnosis of endometrial lesions[J]. J Cancer Res Clin Oncol, 2016, 142(12):2515-2522. doi: 10.1007/s00432-016-2215-3.
pmid: 27515060 |
[7] |
Costas L, Palomero L, Benavente Y, et al. Defining a mutational signature for endometrial cancer screening and early detection[J]. Cancer Epidemiol, 2019, 61:129-132. doi: 10.1016/j.canep.2019.06.003.
pmid: 31238232 |
[8] | Yen TT, Miyamoto T, Asaka S, et al. Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma[J]. Gynecol Oncol, 2018, 150(3):426-431. doi: 10.1016/j.ygyno.2018.06.025. |
[9] |
Bafligil C, Thompson DJ, Lophatananon A, et al. Association between genetic polymorphisms and endometrial cancer risk: a systematic review[J]. J Med Genet, 2020, 57(9):591-600. doi: 10.1136/jmedgenet-2019-106529.
pmid: 32066633 |
[10] | Wang Y, Li L, Douville C, et al. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers[J]. Sci Transl Med, 2018, 10(433):eaap8793. doi: 10.1126/scitranslmed.aap8793. |
[11] |
Akahane T, Kitazono I, Yanazume S, et al. Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens[J]. BMC Med Genomics, 2020, 13(1):101. doi: 10.1186/s12920-020-00753-6.
pmid: 32652986 |
[12] |
Vizza E, Corrado G, De Angeli M, et al. Correction to: Serum DNA integrity index as a potential molecular biomarker in endometrial cancer[J]. J Exp Clin Cancer Res, 2018, 37(1):35. doi: 10.1186/s13046-018-0708-4.
pmid: 29463277 |
[13] | Shen S, Guo J, Lv N, et al. RNA m6A methylation regulators in endometrial cancer (Review)[J]. Int J Oncol, 2022, 61(6):155. doi: 10.3892/ijo.2022.5445. |
[14] | Liew PL, Huang RL, Wu TI, et al. Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings[J]. Clin Epigenetics, 2019, 11(1):170. doi: 10.1186/s13148-019-0765-3. |
[15] | Herzog C, Marín F, Jones A, et al. A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets[J]. J Clin Oncol, 2022, 40(33):3828-3838. doi: 10.1200/JCO.22.00266. |
[16] |
Sangtani A, Wang C, Weaver A, et al. Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection[J]. Gynecol Oncol, 2020, 156(2):387-392. doi: 10.1016/j.ygyno.2019.11.028.
pmid: 31787246 |
[17] |
van den Helder R, Wever B, van Trommel NE, et al. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine[J]. Clin Epigenetics, 2020, 12(1):165. doi: 10.1186/s13148-020-00958-7.
pmid: 33143739 |
[18] |
Dossus L, Kouloura E, Biessy C, et al. Prospective analysis of circulating metabolites and endometrial cancer risk[J]. Gynecol Oncol, 2021, 162(2):475-481. doi: 10.1016/j.ygyno.2021.06.001.
pmid: 34099314 |
[19] | Troisi J, Mollo A, Lombardi M, et al. The Metabolomic Approach for the Screening of Endometrial Cancer: Validation from a Large Cohort of Women Scheduled for Gynecological Surgery[J]. Biomolecules, 2022, 12(9):1229. doi: 10.3390/biom12091229. |
[20] |
Han Y, Park IS, Kim SI, et al. Increasing serum gamma-glutamyltransferase level accompanies a rapid increase in the incidence of endometrial cancer in Korea: A nationwide cohort study[J]. Gynecol Oncol, 2021, 161(3):864-870. doi: 10.1016/j.ygyno.2021.03.024.
pmid: 33795129 |
[21] | Troisi J, Raffone A, Travaglino A, et al. Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal Women[J]. JAMA Netw Open, 2020, 3(9):e2018327. doi: 10.1001/jamanetworkopen.2020.18327. |
[22] |
Trabert B, Eldridge RC, Pfeiffer RM, et al. Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial[J]. Int J Cancer, 2017, 140(3):600-610. doi: 10.1002/ijc.30478.
pmid: 27770434 |
[23] | Qin R, Liao M, Qin W, et al. The diagnostic value of serum YKL-40 in endometrial cancer: a meta-analysis[J]. Biomarkers, 2022, 27(3):215-221. doi: 10.1080/1354750X.2021.2024603. |
[24] | Zhang Q, Yu X, Lin M, et al. Multi-b-value diffusion weighted imaging for preoperative evaluation of risk stratification in early-stage endometrial cancer[J]. Eur J Radiol, 2019, 119:108637. doi: 10.1016/j.ejrad.2019.08.006. |
[25] | Ma X, Ren X, Ma F, et al. Volumetric apparent diffusion coefficient (ADC) histogram metrics as imaging biomarkers for pretreatment predicting response to fertility-sparing treatment in patients with endometrial cancer[J]. Gynecol Oncol, 2022, 165(3):594-602. doi: 10.1016/j.ygyno.2022.04.008. |
[26] | Paraskevaidi M, Morais C, Ashton KM, et al. Detecting Endometrial Cancer by Blood Spectroscopy: A Diagnostic Cross-Sectional Study[J]. Cancers(Basel), 2020, 12(5):1256. doi: 10.3390/cancers12051256. |
[27] | Takahashi Y, Sone K, Noda K, et al. Automated system for diagnosing endometrial cancer by adopting deep-learning technology in hysteroscopy[J]. PLoS One, 2021, 16(3):e0248526. doi: 10.1371/journal.pone.0248526. |
[28] | Lu KH, Broaddus RR. Endometrial Cancer[J]. N Engl J Med, 2020, 383(21):2053-2064. doi: 10.1056/NEJMra1514010. |
[29] |
Lim N, Hickey M, Young GP, et al. Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review[J]. Int J Gynecol Cancer, 2022, 32(5):646-655. doi: 10.1136/ijgc-2021-003132.
pmid: 35437274 |
[30] | Warring SK, Borah B, Moriarty J, et al. The cost of diagnosing endometrial cancer: Quantifying the healthcare cost of an abnormal uterine bleeding workup[J]. Gynecol Oncol, 2022, 164(1):93-97. doi: 10.1016/j.ygyno.2021.10.079. |
[1] | LIN Huan-yu, SHAO Xiao-guang, LU Xu-hong, WANG Qiu-yue, WEI Wei, TONG Chun-yan. Research Status and Hotspots of Fertility Preservation in Female Malignant Tumor Patients from 2004 to 2024 in the Web of Science Core Databases [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 180-186. |
[2] | BAI Yao-jun, WANG Si-yao, LING Fei-fei, ZHANG Sen-huai, LI Hong-li, LIU Chang. Progress of Trop-2 and Targeted Trop-2 Antibody-Coupled Drugs in Gynecological Malignant Tumors [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 1-7. |
[3] | QIU Wan-ning, WEI Yuan. Advances in the Etiological Research of Discordant Anomalies in Monozygotic Twins Pregnancy [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 607-610. |
[4] | CHEN Xing-yu, WEI Ya-jing, LIANG Yan-chun. Advances in Uterine Leiomyosarcoma:Mapping Based on Genomics [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 641-647. |
[5] | HE Qing, HU Hong-bo. Application and Prospects of Artificial Intelligence in the Diagnosis and Treatment of Endometrial Cancer [J]. Journal of International Obstetrics and Gynecology, 2024, 51(5): 572-577. |
[6] | SU Hai-qi, LI Lei. Advances in Methylation Detection for Ovarian Cancer Screening and Diagnosis [J]. Journal of International Obstetrics and Gynecology, 2024, 51(4): 366-369. |
[7] | ZHANG Yi-tian, LI Xiao-li. The Role and Treatment of Mitochondria in Endometrial Carcinoma [J]. Journal of International Obstetrics and Gynecology, 2024, 51(4): 375-379. |
[8] | YAN Hai-yan, YIN Qing-qing, WANG Mei, ZHANG Ai, YE Wen-feng, LI Tian-tian. Broad Ligament Endometrioid Carcinoma: A Case Report [J]. Journal of International Obstetrics and Gynecology, 2024, 51(4): 388-391. |
[9] | GUO Xi, WEI Jia, YANG Yong-xiu. Hormonal Pathways and Regulatory Factors That Lead to Endometrial Disease [J]. Journal of International Obstetrics and Gynecology, 2024, 51(4): 395-400. |
[10] | SI Jing-wen, YU Xiu-jie, SHEN Yan. The Impact of the 2023 FIGO Staging Update of Endometrial Carcinoma on the Content of Pathological Diagnosis [J]. Journal of International Obstetrics and Gynecology, 2024, 51(3): 241-246. |
[11] | WU Xiao-li, LIU Kai-jiang. The TCGA Molecular Classification and New Research Progress in the Treatment of Endometrial Carcinoma [J]. Journal of International Obstetrics and Gynecology, 2024, 51(3): 247-252. |
[12] | ZHOU Lin, YUAN Lin, WAN Yi-cong, ZHANG Lin, CHENG Wen-jun, JIANG Yi. PARP Inhibitors Combined with Immune Checkpoint Inhibitors in the Treatment of Gynecological Malignant Tumors [J]. Journal of International Obstetrics and Gynecology, 2024, 51(2): 206-209. |
[13] | LI Ying-tao, HUANG Xiao-wu. Evolution and Advances in Endometrial Sampling [J]. Journal of International Obstetrics and Gynecology, 2024, 51(1): 105-109. |
[14] | CHEN Yan-xi, LIU Hui, JIANG Peng-cheng. Endometrial Metastasis of Lung Adenocarcinoma with Abnormal Vaginal Bleeding as the First Symptom: A Case Report and Literature Review [J]. Journal of International Obstetrics and Gynecology, 2024, 51(1): 74-77. |
[15] | LI Zhen-ying, SUN Xiao-tong, XING Guang-yang, LI Jing-jing, LIU Ting-ting, ZHANG Yi-fan. Research Progress on Sphingolipid Metabolism and Benign and Malignant Gynecological Diseases [J]. Journal of International Obstetrics and Gynecology, 2023, 50(6): 649-654. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||